These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
219 related items for PubMed ID: 688273
1. Association between steroid hormone receptors and response rate to cytotoxic chemotherapy in metastatic breast cancer. Allegra JC, Lippman ME, Thompson EB, Simon R, Barlock A, Green L, Huff KK, Do HM, Aitken SC, Warren R. Cancer Treat Rep; 1978 Sep; 62(9):1281-6. PubMed ID: 688273 [Abstract] [Full Text] [Related]
2. Distribution, frequency, and quantitative analysis of estrogen, progesterone, androgen, and glucocorticoid receptors in human breast cancer. Allegra JC, Lippman ME, Thompson EB, Simon R, Barlock A, Green L, Huff KK, Do HM, Aitken SC. Cancer Res; 1979 May; 39(5):1447-54. PubMed ID: 427788 [Abstract] [Full Text] [Related]
3. Relationship between the progesterone, androgen, and glucocorticoid receptor and response rate to endocrine therapy in metastatic breast cancer. Allegra JC, Lippman ME, Thompson EB, Simon R, Barlock A, Green L, Huff KK, Do HM, Aitken SC, Warren R. Cancer Res; 1979 Jun; 39(6 Pt 1):1973-9. PubMed ID: 445396 [Abstract] [Full Text] [Related]
4. An association between steroid hormone receptors and response to cytotoxic chemotherapy in patients with metastatic breast cancer. Allegra JC, Lippman ME, Thompson EB, Simon R. Cancer Res; 1978 Nov; 38(11 Pt 2):4299-304. PubMed ID: 698970 [No Abstract] [Full Text] [Related]
5. Impact of metastatic estrogen receptor and progesterone receptor status on survival. Lower EE, Glass EL, Bradley DA, Blau R, Heffelfinger S. Breast Cancer Res Treat; 2005 Mar; 90(1):65-70. PubMed ID: 15770528 [Abstract] [Full Text] [Related]
6. Estrogen, androgen, glucocorticoid, and progesterone receptors in progestin-induced regression of human breast cancer. Teulings FA, van Gilse HA, Henkelman MS, Portengen H, Alexieva-Figusch J. Cancer Res; 1980 Jul; 40(7):2557-61. PubMed ID: 6248208 [Abstract] [Full Text] [Related]
7. Chemotherapy is more effective in patients with breast cancer not expressing steroid hormone receptors: a study of preoperative treatment. Colleoni M, Viale G, Zahrieh D, Pruneri G, Gentilini O, Veronesi P, Gelber RD, Curigliano G, Torrisi R, Luini A, Intra M, Galimberti V, Renne G, Nolè F, Peruzzotti G, Goldhirsch A. Clin Cancer Res; 2004 Oct 01; 10(19):6622-8. PubMed ID: 15475452 [Abstract] [Full Text] [Related]
9. Human epidermal growth factor receptor 2 status correlates with lymph node involvement in patients with estrogen receptor (ER) negative, but with grade in those with ER-positive early-stage breast cancer suitable for cytotoxic chemotherapy. Bartlett JM, Ellis IO, Dowsett M, Mallon EA, Cameron DA, Johnston S, Hall E, A'Hern R, Peckitt C, Bliss JM, Johnson L, Barrett-Lee P, Ellis P. J Clin Oncol; 2007 Oct 01; 25(28):4423-30. PubMed ID: 17906205 [Abstract] [Full Text] [Related]
10. [Steroid receptors and breast carcinoma]. Pasić R, Dulbegović B, Softić D, Wittlif JL. Med Pregl; 1991 Oct 01; 44(1-2):48-51. PubMed ID: 1870463 [Abstract] [Full Text] [Related]
11. Steroid receptors in breast cancer. Desombre ER. Monogr Pathol; 1984 Oct 01; (25):149-74. PubMed ID: 6377047 [Abstract] [Full Text] [Related]
12. Steroid receptors in breast tumors--current status. McGuire WL, Zava DT, Horwitz KB, Chamness GC. Curr Top Exp Endocrinol; 1978 Oct 01; 3():93-129. PubMed ID: 350504 [No Abstract] [Full Text] [Related]
13. [Change in the level of steroid hormone receptors in the tumors of patients with breast cancer complicated by liver and bile duct diseases]. Portnoĭ SM, Smirnova KD, Bassalyk LS, Murav'eva NI, Kuz'mina ZV. Vopr Onkol; 1985 Oct 01; 31(1):55-9. PubMed ID: 3976195 [Abstract] [Full Text] [Related]
16. Steroid receptor analyses of nine human breast cancer cell lines. Horwitz KB, Zava DT, Thilagar AK, Jensen EM, McGuire WL. Cancer Res; 1978 Aug 01; 38(8):2434-7. PubMed ID: 667841 [Abstract] [Full Text] [Related]
18. The association between Akt activation and resistance to hormone therapy in metastatic breast cancer. Tokunaga E, Kataoka A, Kimura Y, Oki E, Mashino K, Nishida K, Koga T, Morita M, Kakeji Y, Baba H, Ohno S, Maehara Y. Eur J Cancer; 2006 Mar 01; 42(5):629-35. PubMed ID: 16464571 [Abstract] [Full Text] [Related]
20. Progesterone receptor status of breast cancer metastases. Branković-Magić M, Janković R, Nesković-Konstantinović Z, Nikolić-Vukosavljević D. J Cancer Res Clin Oncol; 2002 Jan 01; 128(1):55-60. PubMed ID: 11862473 [Abstract] [Full Text] [Related] Page: [Next] [New Search]